Literature DB >> 6945600

Platelet factor 4 is chemotactic for neutrophils and monocytes.

T F Deuel, R M Senior, D Chang, G L Griffin, R L Heinrikson, E T Kaiser.   

Abstract

Platelet factor 4 is shown to be a chemotactic protein for human polymorphonuclear leukocytes and monocytes at concentrations found in human serum and reached locally in injured tissue. The maximum chemotactic response to platelet factor 4 nearly equals that achieved with saturating concentrations of the chemotactic activity derived from the fifth component of human complement, C5. Cells desensitized to C5 chemotactic activity retain chemotactic responsiveness to platelet factor 4. Serum contains inhibitory capacity against the chemotactic activity associated with platelet factor 4. Our results suggest that the local release of platelet factor 4 may be an important stimulus attracting inflammatory cells to sites of blood vessel injury.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945600      PMCID: PMC319837          DOI: 10.1073/pnas.78.7.4584

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Further studies on the chemotactic factor of complement and its formation in vivo.

Authors:  P A Ward; C G Cochrane; H J Muller-Eberhard
Journal:  Immunology       Date:  1966-08       Impact factor: 7.397

2.  Increased vascular permeability produced by human platelet granule cationic extract.

Authors:  R L Nachman; B Weksler; B Ferris
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

3.  Bacterial factors chemotactic for polymorphonuclear leukocytes.

Authors:  P A Ward; I H Lepow; L J Newman
Journal:  Am J Pathol       Date:  1968-04       Impact factor: 4.307

4.  Response of platelets to tissue injury.

Authors:  M A Packham; E E Nishizawa; J F Mustard
Journal:  Biochem Pharmacol       Date:  1968-03       Impact factor: 5.858

5.  The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.

Authors:  P J Lachmann; A B Kay; R A Thompson
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

6.  Macrophage and neutrophil specific chemotactic factors in serum.

Authors:  P C Wilkinson; J F Borel; V J Stecher-Levin; E Sorkin
Journal:  Nature       Date:  1969-04-19       Impact factor: 49.962

7.  Leukotactic factor produced by sensitized lymphocytes.

Authors:  P A Ward; H G Remold; J R David
Journal:  Science       Date:  1969-03-07       Impact factor: 47.728

8.  A neutrophil chemotactic factor from human C'5.

Authors:  P A Ward; L J Newman
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

9.  Release of permeability factors from the blood platelet.

Authors:  J F Mustard; H Z Movat; D R Macmorine; A Sényi
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

10.  A plasmin-split fragment of C'3 as a new chemotactic factor.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

View more
  96 in total

Review 1.  Age-related changes in wound healing.

Authors:  D R Thomas
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Identification and characterization of macrophage inflammatory protein 2.

Authors:  S D Wolpe; B Sherry; D Juers; G Davatelis; R W Yurt; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site.

Authors:  A D Luster; J V Ravetch
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

4.  Constitutive expression of a gene encoding a polypeptide homologous to biologically active human platelet protein in Rous sarcoma virus-transformed fibroblasts.

Authors:  P A Bedard; D Alcorta; D L Simmons; K C Luk; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter.

Authors:  K Ravid; D L Beeler; M S Rabin; H E Ruley; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 6.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

7.  Leukocyte integrin Mac-1 (CD11b/CD18, αMβ2, CR3) acts as a functional receptor for platelet factor 4.

Authors:  Valeryi K Lishko; Valentin P Yakubenko; Tatiana P Ugarova; Nataly P Podolnikova
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

8.  Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin.

Authors:  P S Frenette; R C Johnson; R O Hynes; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Human arterial wall cells secrete factors that are chemotactic for monocytes.

Authors:  T Mazzone; M Jensen; A Chait
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling.

Authors:  Boleslaw K Winiarski; Katarzyna I Wolanska; Srijana Rai; Tahanver Ahmed; Nigel Acheson; Nicholas J Gutowski; Jacqueline L Whatmore
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.